Skip to main content
Top
Published in: Diabetologia 5/2009

01-05-2009 | Short Communication

Potential reno-protective effects of a gluten-free diet in type 1 diabetes

Authors: V. Malalasekera, F. Cameron, E. Grixti, M. C. Thomas

Published in: Diabetologia | Issue 5/2009

Login to get access

Abstract

Aims/hypothesis

Coeliac disease is common in type 1 diabetes. It is managed with a gluten-free diet, characterised by foods low in AGEs. We hypothesised that this diet would lead to lower plasma AGEs and be associated with reduced albuminuria.

Methods

From a single paediatric clinic, we recruited 21 children with type 1 diabetes and biopsy-proven coeliac disease, and 38 individuals with diabetes alone. The groups were matched for age, sex, duration of disease and metabolic control. Participants completed a detailed clinical and dietary history. Blood samples were taken for HbA1c, coeliac serology, thyroid function, serum IgA levels and plasma AGEs, and urine samples were obtained for estimation of the albumin/creatinine ratio (ACR).

Results

All the individuals with coeliac disease were asymptomatic, with negative transglutaminase antibodies. There were no significant differences between the groups in terms of age (14 years), sex (29% male), duration of diabetes (7 years), mean HbA1c (8.3%), lipid levels or treatment regimens. However, children with diabetes and coeliac disease had twofold lower levels of urinary ACR than with those diabetes alone (p = 0.04). This was associated with lower levels of circulating AGEs (p = 0.03). These associations were independent of metabolic control, diabetes management and other potentially confounding variables, such as household exposure to cigarette smoke.

Conclusions/interpretation

Adherence to a gluten-free diet may provide additional benefits for individuals with coeliac disease, and potentially those with type 1 diabetes.
Literature
2.
go back to reference Forbes JM, Cooper ME, Oldfield MD, Thomas MC (2003) Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 14:S254–S258PubMedCrossRef Forbes JM, Cooper ME, Oldfield MD, Thomas MC (2003) Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 14:S254–S258PubMedCrossRef
3.
go back to reference Vlassara H, Striker G (2007) Glycotoxins in the diet promote diabetes and diabetic complications. Curr Diab Rep 7:235–241PubMedCrossRef Vlassara H, Striker G (2007) Glycotoxins in the diet promote diabetes and diabetic complications. Curr Diab Rep 7:235–241PubMedCrossRef
4.
go back to reference Thomas MC, Forbes JM, MacIsaac R, Jerums G, Cooper ME (2005) Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more? Ann N Y Acad Sci 1043:644–654PubMedCrossRef Thomas MC, Forbes JM, MacIsaac R, Jerums G, Cooper ME (2005) Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more? Ann N Y Acad Sci 1043:644–654PubMedCrossRef
5.
go back to reference Stone ML, Craig ME, Chan AK, Lee JW, Verge CF, Donaghue KC (2006) Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study. Diabetes Care 29:2072–2077PubMedCrossRef Stone ML, Craig ME, Chan AK, Lee JW, Verge CF, Donaghue KC (2006) Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study. Diabetes Care 29:2072–2077PubMedCrossRef
6.
go back to reference Saadah OI, Zacharin M, O’Callaghan A, Oliver MR, Catto-Smith AG (2004) Effect of gluten-free diet and adherence on growth and diabetic control in diabetics with coeliac disease. Arch Dis Child 89:871–876PubMedCrossRef Saadah OI, Zacharin M, O’Callaghan A, Oliver MR, Catto-Smith AG (2004) Effect of gluten-free diet and adherence on growth and diabetic control in diabetics with coeliac disease. Arch Dis Child 89:871–876PubMedCrossRef
7.
go back to reference Cordovado SK, Zhao Y, Warram JH et al (2008) Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes 57:518–522PubMedCrossRef Cordovado SK, Zhao Y, Warram JH et al (2008) Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes 57:518–522PubMedCrossRef
Metadata
Title
Potential reno-protective effects of a gluten-free diet in type 1 diabetes
Authors
V. Malalasekera
F. Cameron
E. Grixti
M. C. Thomas
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1277-z

Other articles of this Issue 5/2009

Diabetologia 5/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine